Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stevenson

Showing results (501-510 of 550) with videos related to

Pageof 55
Sort By:
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
American Journal of Human Genetics|March 18, 2008
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndromeGregor D Gilfillan, Kaja K Selmer, Ingrid Roxrud, et al.
Cell Chemical Biology|June 8, 2023
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutationMatthew L Arwood, Yao Liu, Shannon K Harkins, et al.
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Cancer Discovery|May 2, 2019
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating AgentsChen Lossos, Yunpeng Liu, Kellie E Kolb, et al.
Blood Advances|December 5, 2023
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.
Blood|December 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Wenchao Wu, Geoffrey M Nelson, Raphael Koch, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 6, 2021
Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disordersBekim Sadikovic, Michael A Levy, Jennifer Kerkhof, et al.
Pageof 55

Showing results (501-510 of 550) with videos related to

Sort By:
Pageof 55
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
American Journal of Human Genetics|March 18, 2008
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndromeGregor D Gilfillan, Kaja K Selmer, Ingrid Roxrud, et al.
Cell Chemical Biology|June 8, 2023
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutationMatthew L Arwood, Yao Liu, Shannon K Harkins, et al.
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Cancer Discovery|May 2, 2019
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating AgentsChen Lossos, Yunpeng Liu, Kellie E Kolb, et al.
Blood Advances|December 5, 2023
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.
Blood|December 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Wenchao Wu, Geoffrey M Nelson, Raphael Koch, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 6, 2021
Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disordersBekim Sadikovic, Michael A Levy, Jennifer Kerkhof, et al.
Pageof 55